Quick answer
Sexual side effects after BPH treatment should be separated into ejaculation, erections, orgasm and fertility-related concerns. UroLift, Rezūm, TURP, HoLEP and Aquablation use different mechanisms, so a single “sexual side effect rate” is too crude for a useful decision.
What this page helps you decide
- Ejaculation is not erectile function
- Mechanism changes the sexual conversation
- What to document before treatment
Evidence used on this page: NIDDK: Enlarged Prostate (BPH) · NIDDK: Urologic Diseases in America 2024, BPH/LUTS · FDA: Patient-reported outcomes for BPH devices
Ejaculation is not erectile function
A man can have reliable erections and still experience reduced, absent or retrograde ejaculation. Conversely, erectile dysfunction can occur for vascular, neurologic, medication-related or psychological reasons unrelated to the amount of ejaculate. Procedure counseling should therefore name the outcome being discussed.
Mechanism changes the sexual conversation
UroLift retracts tissue with implants. Rezūm thermally treats selected tissue. TURP resects tissue. HoLEP enucleates adenoma. Aquablation removes mapped tissue with a waterjet. Because those techniques interact with the bladder neck and prostate differently, sexual priorities should be discussed procedure by procedure rather than inherited from a generic template.
What to document before treatment
- Baseline erection quality
- Current ejaculation volume and direction
- Libido
- Orgasmic sensation
- Fertility goals
- Use of tadalafil or other erectile-function medication
- Previous prostate or pelvic procedures
Questions for informed consent
- What is the expected effect on ejaculation for the exact technique you plan?
- How do you distinguish ejaculation changes from erectile dysfunction?
- Could the procedure affect fertility?
- What is your center’s experience with this technique?
- Does my anatomy change the sexual-risk discussion?
Sexual side effects are not one outcome
The phrase “sexual side effects” hides several different outcomes: erectile function, ejaculation, orgasmic sensation, semen volume, fertility concerns and the psychological effect of urinary symptoms on sexual confidence. A good procedure comparison separates these instead of assigning each treatment a vague label such as “sex friendly.”
Ejaculation is often the most procedure-sensitive domain, while erectile outcomes may be influenced by baseline vascular health, medications, age and the procedure itself. A man who places high value on preserving antegrade ejaculation may therefore rank options differently from someone whose overriding problem is severe obstruction or recurrent retention.
Compare procedures by the sexual outcome you actually care about
| Decision dimension | Questions to ask |
|---|---|
| Ejaculation | How often does this procedure change forward ejaculation in this practice, and is the change expected to be temporary or persistent? |
| Erections | What is my baseline erectile function, and what does the evidence suggest for this procedure in men like me? |
| Orgasm | Can orgasmic sensation change even if erections are preserved? |
| Fertility | Would a change in semen volume or direction matter for future fertility plans? |
| Medication reduction | Could stopping a drug that caused sexual symptoms improve the overall sexual picture after successful treatment? |
The hierarchy of priorities changes the “best” procedure
For one person, preserving ejaculation may justify accepting a higher chance of retreatment or a narrower range of anatomic suitability. For another, maximizing durable relief from obstruction may matter more than preserving semen emission. Those are not contradictory preferences. They are different utility functions, which is exactly why a generic ranking of procedures is misleading.
The comparison should also include the possibility that current medication is contributing to sexual symptoms. If a 5-alpha-reductase inhibitor or alpha blocker is part of the problem, a successful procedure that reduces medication dependence can change the sexual outcome indirectly. That possibility should be discussed rather than assumed.
What to document before the procedure discussion
- Baseline erectile function and whether PDE5 inhibitors are already used.
- Current ejaculation pattern and whether preservation is a high priority.
- Current BPH medications and which sexual symptoms appeared after treatment started.
- Prostate size, anatomy, retention history and severity of obstruction.
- Willingness to accept retreatment in exchange for a less invasive approach.
- Whether future fertility is relevant.
Why baseline sexual function changes the interpretation
Procedure-related sexual outcomes are difficult to interpret without a baseline. A man who already has erectile dysfunction, low semen volume or reduced orgasmic intensity can experience a different post-treatment change from someone with normal baseline function. Medication use, diabetes, vascular disease, age and relationship factors can further complicate attribution.
For this reason, documenting baseline erections, ejaculation and orgasmic function is more useful than relying on a single global question about sex. It gives the patient and clinician something concrete to compare after treatment and reduces the chance that every later change is automatically blamed on the procedure.
Ejaculation preservation and obstruction relief can pull in different directions
Procedures that prioritize preservation of ejaculation may appeal strongly to younger men or to anyone for whom antegrade ejaculation is an important quality-of-life outcome. But a patient with severe obstruction, retention or anatomy better suited to a tissue-removing operation may place more weight on durable decompression than on semen preservation.
This is not a contest between 'good' and 'bad' procedures. It is a trade-off between competing outcomes. The decision becomes clearer when the patient ranks priorities before hearing a procedural recommendation, because otherwise the ranking tends to change after each marketing claim or anecdote.
What to ask the surgeon about sexual outcomes
Published averages are useful, but surgeon-specific counseling matters. Ask how the chosen procedure affects ejaculation in the surgeon's own practice, whether the effect is expected to be temporary or persistent, how erectile outcomes are monitored, and what happens if sexual symptoms appear after treatment.
It is also worth asking whether successful treatment could allow reduction of a medication that was already contributing to sexual symptoms. In some patients, the net sexual outcome after a procedure reflects both the procedure itself and changes in the medication regimen.
Evidence used on this page
Major treatment claims are anchored to the sources cited on this page, prioritizing official drug labeling, government health agencies, regulators, and professional guidelines.
- Government health source
- Regulatory source
Sources
- NIDDK: Enlarged Prostate (BPH)
- NIDDK: Urologic Diseases in America 2024, BPH/LUTS
- FDA: Patient-reported outcomes for BPH devices
Educational information only. This page does not diagnose BPH, determine procedure eligibility, or tell you to start, stop or change prescription medication.